ArticleJournal of cardiothoracic surgery2025
The role of circ_0050908 in acute myocardial infarction (AMI) and its predictive value for AMI.
Article in Journal of cardiothoracic surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Expression profiles and bioinformatic analysis of circular RNA in rheumatic heart disease: potential hsa_circ_0001490 and hsa_circ_0001296 as a diagnostic biomarker.Frontiers in cardiovascular medicine · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveAcute myocardial infarction (AMI) is a serious condition that significantly affects human health and is classified as an Acute Coronary Syndrome (ACS). Timely diagnosis of AMI is currently paramount for guiding its treatment. The objective of this research is to examine the influence of circ_0050908 in AMI and its potential as a predictive marker for the condition.
methodsThe study included 110 patients with AMI, along with 82 healthy volunteers. The expression levels of circ_0050908 in the healthy control group, AMI patients, and AC16 cells were validated using the qRT-PCR method. The diagnostic value of circ_0050908 for AMI was assessed through binary logistic regression analysis and ROC curve analysis. An AMI cell model was constructed by subjecting AC16 cells to hypoxia-reoxygenation treatment. To assess cell viability and apoptosis, the researchers utilized the CCK-8 assay and flow cytometry techniques. The relationship between circ_0050908 and miR-338-3p was validated through dual-luciferase reporter assays and RNA immunoprecipitation (RIP) tests.
resultscirc_0050908 was found to be significantly elevated in AMI patients, while the levels of its target, miR-338-3p, were significantly reduced. Furthermore, circ_0050908 demonstrated strong predictive ability for AMI. Silencing circ_0050908 showed protective effects against H/R-induced damage to myocardial cells, leading to enhanced cell survival and decreased inflammatory responses, along with decreased myocardial injury markers CK-MB and cTnT. However, transfection with miR-338-3p inhibitor suppressed these protective effects.
conclusionThis study indicated that circ_0050908 has potential value as a diagnostic biomarker for AMI and explored the function of the circ_0050908/miR-338-3p axis in the mechanism underlying AMI.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.